Capecitabine (X) and taxanes in patients (pts) with anthracycline-pretreated metastatic breast cancer (MBC): sequential vs. combined therapy results from the Mexican Oncology Study Group.

被引：0
|
作者：
Torrecillas, L [1 ]
Soto, C [1 ]
Cervantes, G [1 ]
Benitez, H [1 ]
Acosta, A [1 ]
Cortes, P [1 ]
Gonzalez, F [1 ]
Zamora, R [1 ]
Rodriguez, G [1 ]
Silva, A [1 ]
Leoner, C [1 ]
Sauza, F [1 ]
Suarez, T [1 ]
Tokunaga, J [1 ]
Erazo, A [1 ]
Talavera, J [1 ]
机构：
[1] IMSS, Mexico City, DF, Mexico
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S200 / S200
页数：1
相关论文
共 50 条
  • [31] Capecitabine (X) and etoposide (E) for patients (pts) with locally advanced or metastatic gastric cancer: a Mexican Oncology Study Group phase II trial
    Aldaco, F.
    Reyes, S.
    Tellez, E.
    Torrecillas, L.
    Soto, C.
    Fernandez, R.
    Garcia-Juarez, R.
    Cervantes, G.
    Saenz, J.
    Capdeville, D.
    EJC SUPPLEMENTS, 2005, 3 (02): : 215 - 215
  • [32] Mitomycin-C (MMC) in combination with capecitabine (mixel) as third line chemotherapy in anthracycline and taxane pretreated metastatic breast cancer patients (MBC): Results of pilot study
    Maisano, Roberto
    Caristi, Nicola
    Mare, Marzia
    Mafodda, Antonino
    Iorfida, Monica
    Montalto, Erika
    Carboni, Rita
    Nardi, Mario
    ANNALS OF ONCOLOGY, 2005, 16 : 15 - 15
  • [33] Quality of life (QoL) improvements in 1464 patients (pts) with metastatic breast cancer (MBC) receiving capecitabine (X) in Brazil: Implications for oncology nurses
    Testa, C.
    Martins, F.
    GonAalves, D.
    Huttener, C.
    Aguiar, O.
    Oliveira, A.
    Pereira, C.
    Soffiatti, N.
    Ferro, R.
    Zamprogna, L.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2006, 10 (03) : 229 - 229
  • [34] Epirubicin/paclitaxel (EP) vs. capecitabine/paclitaxel (XP) in first-line metastatic breast cancer (MBC):: A prospective, randomized multicentre phase III study of the AGO breast cancer study group.
    Lueck, H.
    Minckwitz, G. V.
    Du Bois, A.
    Schrader, I.
    Huober, J.
    Heilmann, V.
    Beckmann, M.
    Stähle, A.
    Jackisch, C.
    Marth, C.
    Richter, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 7S - 7S
  • [35] A pilot study of weekly versus 3-week docetaxel in combination with capecitabine in patients with anthracycline-pretreated metastatic breast cancer (CHN-TAX 614)
    Jiang, Z.
    Zhang, S.
    Song, S.
    Ren, J.
    Jiao, S.
    Liu, D.
    Sun, Q.
    Wang, H.
    Xie, X.
    Liu, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 122 - 123
  • [36] Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study
    Awada, A.
    Albanell, J.
    Canney, P. A.
    Dirix, L. Y.
    Gil, T.
    Cardoso, F.
    Gascon, P.
    Piccart, M. J.
    Baselga, J.
    BRITISH JOURNAL OF CANCER, 2008, 98 (09) : 1500 - 1507
  • [37] Gemcitabine-oxaliplatin combination (SEGEMOX) in anthracycline (A) and taxanes (T) pretreated metastatic breast cancer (MBC): Results from the GERCOR-SEGEMOX phase II trial
    Gligorov, J.
    Cals, L.
    Tournigand, C.
    Merad, Z.
    Dutel, J.
    Selle, F.
    Zeghib, N.
    Chibaudel, B.
    Cvitkovic, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Phase II study of eribulin mesylate (E7389) in patients (pts) with locally advanced or metastatic breast cancer (MBC) previously treated with anthracycline, taxane, and capecitabine therapy
    Vahdat, L. T.
    Twelves, C.
    Allison, M. K.
    Cortes, J. A.
    Campone, M.
    Shuster, D. E.
    Wanders, J.
    Fang, F.
    Gurnani, R. D.
    Blum, J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study
    A Awada
    J Albanell
    P A Canney
    L Y Dirix
    T Gil
    F Cardoso
    P Gascon
    M J Piccart
    J Baselga
    British Journal of Cancer, 2008, 98 : 1500 - 1507
  • [40] INTEGRATION OF CAPECITABINE (X) MONOTHERAPY WITH X COMBINATION THERAPY IN PATIENTS WITH METASTATIC BREAST CANCER (MBC): RATIONALE AND DESIGN OF X MAINTENANCE STUDY
    Wang, J.
    Xu, B.
    ANNALS OF ONCOLOGY, 2010, 21 : 120 - 120
12345